Evidence map›Paper›PMID 24805101›Full record

ArticlePloS one2014

Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent.

Christine M Freeman, Alexandra L McCubbrey, Sean Crudgington, Joshua Nelson, Fernando J Martinez, MeiLan K Han, George R Washko, Stephen W Chensue, Douglas A Arenberg, Catherine A Meldrum and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00281229 (Innate and Adaptive Immunity in COPD Exacerbations), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00281229 completednot on this map

Innate and Adaptive Immunity in COPD Exacerbations: Surgical Volunteers

TypeobservationalSponsorUniversity of MichiganRan2005 to 2015Enrolled481ConditionsPulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Predominant lung cDC2 phenotype in cigarette smoke-exposed mice favors polarization of IL-17-producing CD4American journal of physiology. Lung cellular and molecular physiology · 2026
    Article
  3. Role of Regulatory T Cells in Pulmonary Ageing and COPD Development.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. To Bet or Not to Bet on T-bet As a Therapeutic Target in Emphysema?American journal of respiratory cell and molecular biology · 2019
    Article
  8. At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2018
    Article
  9. Review
  10. Emerging pharmaceutical therapies for COPD.International journal of chronic obstructive pulmonary disease · 2017
    Review
  11. COPD immunopathology.Seminars in immunopathology · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Christine M FreemanResearch Service, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America; Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
Alexandra L McCubbreyGraduate Program in Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.
Sean CrudgingtonPulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
Joshua NelsonPulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
Fernando J MartinezPulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
MeiLan K HanPulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
George R WashkoDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham & Womans Hospital and Harvard University, Boston, Massachusetts, United States of America.
Stephen W ChensueGraduate Program in Immunology, University of Michigan, Ann Arbor, Michigan, United States of America; Pathology and Laboratory Medicine Service, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America; Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
Douglas A ArenbergPulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
Catherine A MeldrumPulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
Lisa McCloskeyPulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
Jeffrey L CurtisPulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America; Graduate Program in Immunology, University of Michigan, Ann Arbor, Michigan, United States of America; Pulmonary and Critical Care Medicine Section, Medicine Service, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America.
Michigan Medicine · USMichigan United · USUniversity of Michigan–Ann Arbor · USWoman's Hospital · US

Funding

MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
Innate and adaptive immunity in COPD exacerbationsR01HL082480 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CURTIS, JEFFREY LOUIS · 2005 to 2009
$2.4M
PREDICTING RESPONSE TO THERAPY IN IDIOPATHIC PULMONARY FK24HL004212 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARTINEZ, FERNANDO J · 2000 to 2009
$1.2M
Impact of Gender on Symptoms and Progression of IPFK23HL093351 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAN, MEILAN K · 2009 to 2013
$553k
BLRD VA I01 BX001389NCI NIH HHS P30 CA46952NCRR NIH HHS UL1 RR024986NHLBI NIH HHS K23 HL093351NHLBI NIH HHS K24 HL004212NHLBI NIH HHS K24 HL04212NHLBI NIH HHS N01 HR046162NHLBI NIH HHS R01 HL082480NIAID NIH HHS T32 AI007413
6 · The paper itself

Abstract

unlabelledLung CD4+ T cells accumulate as chronic obstructive pulmonary disease (COPD) progresses, but their role in pathogenesis remains controversial. To address this controversy, we studied lung tissue from 53 subjects undergoing clinically-indicated resections, lung volume reduction, or transplant. Viable single-cell suspensions were analyzed by flow cytometry or underwent CD4+ T cell isolation, followed either by stimulation with anti-CD3 and cytokine/chemokine measurement, or by real-time PCR analysis. In lung CD4+ T cells of most COPD subjects, relative to lung CD4+ T cells in smokers with normal spirometry: (a) stimulation induced minimal IFN-γ or other inflammatory mediators, but many subjects produced more CCL2; (b) the T effector memory subset was less uniformly predominant, without correlation with decreased IFN-γ production. Analysis of unstimulated lung CD4+ T cells of all subjects identified a molecular phenotype, mainly in COPD, characterized by markedly reduced mRNA transcripts for the transcription factors controlling TH1, TH2, TH17 and FOXP3+ T regulatory subsets and their signature cytokines. This mRNA-defined CD4+ T cell phenotype did not result from global inability to elaborate mRNA; increased transcripts for inhibitory CD28 family members or markers of anergy; or reduced telomerase length. As a group, these subjects had significantly worse spirometry, but not DLCO, relative to subjects whose lung CD4+ T cells expressed a variety of transcripts. Analysis of mRNA transcripts of unstimulated lung CD4+ T cell among all subjects identified two distinct molecular correlates of classical COPD clinical phenotypes: basal IL-10 transcripts correlated independently and inversely with emphysema extent (but not spirometry); by contrast, unstimulated IFN-γ transcripts correlated independently and inversely with reduced spirometry (but not reduced DLCO or emphysema extent). Aberrant lung CD4+ T cells polarization appears to be common in advanced COPD, but also exists in some smokers with normal spirometry, and may contribute to development and progression of specific COPD phenotypes.

trial registrationClinicalTrials.gov as NCT00281229.

Indexed as

Gene ExpressionAgedCD4-Positive T-LymphocytesCytokinesFemaleHumansLungLymphocyte ActivationMaleMiddle AgedPulmonary Disease, Chronic ObstructivePulmonary EmphysemaSeverity of Illness IndexCytokines

Identifiers

PMID24805101
PMCPMC4013040
OpenAlexW2100792431

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.